REFERENCE RECONSTITUTION INFORMATION
RECOMMENDED RECONSTITUTION GUIDE This guide explains how research peptides are commonly reconstituted using bacteriostatic water (BAC water), and shows how dosing volumes correspond to syringe units. Always follow sterile preparation techniques when handling research peptides.
Always follow sterile preparation techniques when handling research peptides.
⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
General Preparation
⚠️ Important: Allow product vial and BAC water to reach room temperature before reconstituting to reduce condensation uptake
- Use bacteriostatic water (BAC water) only
- Inject water slowly down the inside of the vial
- Do not shake the vial
- Gently swirl to dissolve the peptide powder
- Store refrigerated after mixing
- Use sterile technique when handling
SELANK (10mg) - RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of Selank 10mg.
RouteSubcutaneous injectionScheduleDaily subcutaneous injections for 4-week cycles with 4-week breaks (8–16 weeks total)Injection SitesRotate injection sites (abdomen, thighs, upper arms)DosingDose Range: 0.30–0.50 mg daily with gradual titration
- Use sterile technique when handling and administering
- Goal: Support reduction of anxiety and neurasthenia symptoms with anti-asthenic benefits
- Cycle Pattern: 4 weeks on, 4 weeks off
- Optional: 5 days on / 2 days off
- Timing: Any consistent time
- Storage - Lyophilized: Store at −20 °C for long-term stability; refrigeration acceptable short-term
- Storage - Reconstituted: Refrigerate at 2–8 °C; stable ~1 month
- Allow vial to reach room temperature before opening
Reference Parameters (Dosing Protocol (2ml BAC Water; ~5.00 mg/ml))
WEEKDOSE PER INJECTIONUNITS (PER INJECTION) (ML)Weeks 1–20.30 mg6 units (0.06ml)Weeks 3–40.50 mg10 units (0.10ml)Reference interval:Once per day subcutaneous injection. Goal: Support reduction of anxiety and neurasthenia symptoms with anti-asthenic benefits.For laboratory research only.
Reference Parameters (Dosing Protocol (3ml BAC Water; ~3.33 mg/ml))
WEEKDOSE PER INJECTIONUNITS (PER INJECTION) (ML)Weeks 1–20.30 mg9 units (0.09ml)Weeks 3–40.50 mg15 units (0.15ml)Reference interval:Once per day subcutaneous injection. Goal: Support reduction of anxiety and neurasthenia symptoms with anti-asthenic benefits.For laboratory research only.
Experimental Study Period
STUDY PERIOD4–8 weeksWASHOUT PERIOD2–4 weeks
